Every Form 4 that Texas Capital Bancshares, Inc. (TCBI) has filed with the SEC in the last 12 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A Form 4 covers the transactions officers, directors and large holders report, so if you follow TCBI and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full TCBI filings page.
Texas Capital Bancshares Chief Financial Officer John Matthew Scurlock reported multiple equity award transactions in company stock. On January 27, 2026, he received 14,981 2026 restricted stock units, which vest in three equal annual installments beginning January 27, 2027.
On January 29, 2026, 2,677 2025 restricted stock units were converted into an equal number of common shares at an exercise price of $0, increasing his directly held common stock to 19,435 shares before a subsequent disposition. That same day, he disposed of 1,124 common shares at $98.87 per share, leaving 18,311 common shares owned directly. The filing also notes that beneficial ownership was adjusted by 950 shares to correct a previous calculation error, and that the 2025 restricted stock units vest in three equal annual installments beginning January 28, 2026.
Texas Capital Bancshares Inc. director-related entity reports preferred share purchase. On 01/23/2026, SCG Ventures LP, an entity associated with director Robert W. Stallings, purchased 2,000 Depositary Shares for Series B Preferred Stock at an average price of $20.91 per depositary share. Each depositary share represents a 1/40th interest in a share of the company’s 5.75% Fixed Rate Non-Cumulative Perpetual Preferred Stock, Series B.
After this transaction, SCG Ventures LP is shown as indirectly holding 277,913 depositary shares and 90,039 shares of common stock. Separately, the Stallings Foundation, a charitable foundation where Mr. Stallings is an officer, is listed with 60,000 depositary shares. Direct holdings are also reported at 84,587 depositary shares and 289,961 common shares.
Texas Capital Bancshares director Laura L. Whitley reported open-market purchases of the company’s common stock. On January 23, 2026, she bought 500 shares at a price of $97.56 per share. She then purchased another 500 shares on January 26, 2026 at $97.51 per share. Following these transactions, Whitley directly owned 7,961 shares of Texas Capital Bancshares common stock.
Texas Capital Bancshares (TCBI) reported an insider equity transaction by its Chief Legal Officer. On 11/05/2025, 5,170 shares of common stock were acquired upon settlement of equity awards, followed by the withholding of 2,035 shares to satisfy taxes at $85.22 per share. Following these transactions, the officer directly holds 23,555 shares.
Texas Capital Bancshares (TCBI) reported an insider Form 4 transaction. On 10/28/2025, the company’s Chief Legal Officer disposed of 177 shares of common stock at $0 per share (transaction code G).
After this transaction, the officer directly beneficially owns 20,420 shares.
Texas Capital Bancshares (TCBI) director reported an open‑market purchase of 5,000 Depositary Shares for Series B Preferred Stock on 10/28/2025 at an average price of $20.83 (prices ranged from $20.78 to $20.88).
Each Depositary Share represents a 1/40th interest in the issuer’s 5.75% Fixed Rate Non‑Cumulative Perpetual Preferred Stock, Series B. Following the transaction, the filing shows indirect beneficial ownership of 275,913 Depositary Shares via SCG Ventures LP, alongside other reported holdings of common stock and Depositary Shares across direct and indirect accounts.
Texas Capital Bancshares (TCBI): Director insider buys
A director reported open‑market purchases of Depositary Shares for Series B Preferred Stock. The transactions were 10,000 shares at $20.61 on 10/24/2025 and 5,000 shares at $20.68 on 10/27/2025, held indirectly through SCG Ventures LP. Each Depositary Share represents a 1/40th interest in the company’s 5.75% Fixed Rate Non‑Cumulative Perpetual Preferred Stock, Series B.
Following these trades, beneficial holdings include 270,913 Depositary Shares indirect via SCG Ventures LP, 60,000 Depositary Shares indirect via the Stallings Foundation, and 84,587 Depositary Shares held directly. Common stock holdings are 90,039 shares indirect via SCG Ventures LP and 289,961 shares held directly.